ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesACCC eLearning LogInPresentations & Abstracts
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
5425 Wisconsin Ave #600, Chevy Chase, MD 20815
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeEducation & Resources

CMS Releases Final Rule to the Radiation Oncology Model

November 3, 2021

On November 2, 2021, the Centers for Medicare & Medicaid Services (CMS) released the CY 2022 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems final rule (CMS-1753-F). This announcement includes the finalized modifications to the Radiation Oncology (RO) Model.

The RO Model is set to begin January 1, 2022, and end December 31, 2026. The proposed rule includes the summarized modifications below:

  • Adjustment to the pricing methodology (updated baseline period is 2017 to 2019 and lowered discounts to 3.5 and 4.5) for the professional component and technical component, respectively
  • Removal of brachytherapy from included modalities
  • Removal of liver cancer from included cancer types
  • Finalization of cases in which a beneficiary switches from traditional fee-for-service (FFS) to Medicare Advantage during an episode and before treatment is complete. CMS will consider this an incomplete episode and radiation therapy services will be paid under FFS.
  • Modification to the current Pennsylvania Rural Health Model (PARHM) overlap policy to only exclude hospitals participating in the model, no just PARHM-eligible hospitals
  • Addition of an overlap policy for the Community Track of the CHART Model
  • Addition of an extreme and uncontrollable circumstances policy.

For additional information on the RO Model and CMS' final rules, visit the RO Model website or read more on thefinal rule. For questions on the model or for participants needing their model ID, contact RadiationTherapy@cms.hhs.gov.

Posted 11/3/2021

Related Content

FDA Approves Zenocutuzumab-zbco for Advanced, Unresectable, or Metastatic Cholangiocarcinoma

May 12, 2026

FDA Approves Vepdegestrant for ER-positive, HER2-negative, ESR1-mutated Advanced or Metastatic Breast Cancer

May 8, 2026

Upcoming Events

Virtual ACCC Oncology Reimbursement Meeting

Virtual ACCC Oncology Reimbursement Meeting

Virtual August 13, 2026 at 11:00 AM EDT
Register Now!
ACCC 43rd National Oncology Conference

ACCC 43rd National Oncology Conference

In Person October 21, 2026 at 8:00 AM EDT450 Summer St, Boston, MA 02210, USAOmni Boston Hotel at the Seaport, Boston
Register Now!
ACCC Oncology Reimbursement Meeting | Reno

ACCC Oncology Reimbursement Meeting | Reno

In Person November 4, 2026 at 8:00 AM EST255 North Virginia Street, Reno, NV, USAWhitney Peak Hotel Reno, Tapestry Collection by Hilton,
Register Now!
ACCC Oncology Reimbursement Meeting | Providence

ACCC Oncology Reimbursement Meeting | Providence

In Person November 10, 2026 at 8:00 AM EST5 Avenue of the Arts, Providence, RI, USARenaissance Providence Downtown Hotel,
Register Now!
HSCO 2026 August Dinner Symposium
Oncology

HSCO 2026 August Dinner Symposium

In Person Conference & ConventionAugust 12, 2026 at 5:30 PM HST6600 Kalanianaʻole Highway suite 110, Honolulu, HI 96825, USARoy's Restaurants – Hawaii Kai, Honolulu
Register Now!
LOS 2026 Cancer Congress - National Oncology Updates
Oncology

LOS 2026 Cancer Congress - National Oncology Updates

In Person Conference & ConventionAugust 14, 2026 at 11:00 AM CDT859 Convention Center Blvd, New Orleans, LA, USANew Orleans Marriott Warehouse Art District, New Orleans
Register Now!
LOS Cancer Congress After-Hours: Bowling Social
Oncology

LOS Cancer Congress After-Hours: Bowling Social

In Person Conference & ConventionAugust 14, 2026 at 6:30 PM CDT600 Fulton St, New Orleans, LA 70130, USAFulton Alley, New Orleans
Register Now!
IOS Evansville Meeting
Oncology

IOS Evansville Meeting

In Person Conference & ConventionAugust 18, 2026 at 5:30 PM CDT4011 Gateway Blvd, Newburgh, IN 47630, USADeaconess Gateway Hospital , Newburgh
Register Now!
2026 Carolinas Cancer Conference
Oncology

2026 Carolinas Cancer Conference

In Person Conference & ConventionAugust 22, 2026 at 7:00 AM EDT5757 Palm Blvd, Isle of Palms, SC, USAWild Dunes, Isle of Palms
Register Now!
IOS 2026 Best of ASCO
Oncology

IOS 2026 Best of ASCO

In Person Conference & ConventionAugust 22, 2026 at 6:30 AM CDT300 East 9th Street, Coralville, IA, USAHyatt Regency Coralville Hotel & Conference Center, Coralville
Register Now!
NMSCO 2026 Fall Conference
Oncology

NMSCO 2026 Fall Conference

In Person Conference & ConventionSeptember 12, 2026 at 7:30 AM MDT2101 Louisiana Boulevard NE Albuquerque, NM, 87110Marriott Albuquerque, Albuquerque
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Transforming Access to Care Through Pre-Intake Navigation

Transforming Access to Care Through Pre-Intake Navigation

The University of Texas MD Anderson Cancer Center in Houston, Texas, developed a novel Pre-Intake Navigation (PIN) program, which identifies and resolves early financial and insurance barriers, enabling patients to access timely, high-quality cancer care with less anxiety and fewer delays. PIN shifts financial navigation from a late-stage, reactive task to an early, standardized, patient‑centered process embedded in the call center workflow.

An APP-Led Outpatient Bispecific Antibody Clinic

An APP-Led Outpatient Bispecific Antibody Clinic

Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.

FDA Approves Relacorilant With Nab-paclitaxel for Platinum-resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

March 26, 2026

FDA Approves Nivolumab With Chemotherapy for Previously Untreated Hodgkin Lymphoma

March 26, 2026

FDA Approves Teclistamab in Combination With Daratumumab Hyaluronidase-fihj for Relapsed or Refractory Multiple Myeloma

March 6, 2026

FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-squamous Non-small Cell Lung Cancer

March 4, 2026

FDA Grants Traditional Approval to Encorafenib for Metastatic Colorectal Cancer With a BRAF V600E Mutation

March 4, 2026

FDA Approves Acalabrutinib With Venetoclax for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

February 20, 2026

Advancing Critical Priorities at the State Level: Louisiana, Iowa, and Washington Awarded for Their Efforts at 2026 ASCO Annual Meeting

Advancing Critical Priorities at the State Level: Louisiana, Iowa, and Washington Awarded for Their Efforts at 2026 ASCO Annual Meeting

At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.

Designing a Safe, Fully Outpatient CAR T-Cell Program in the Community

Designing a Safe, Fully Outpatient CAR T-Cell Program in the Community

Nationally, approximately 1 in 5 patients who qualify for CAR T-cell therapy never receive it due to geographic distance, travel burden, or limited availability at specialized inpatient centers. Recognizing a critical need in its community, Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana, launched the region’s first fully outpatient CAR T-cell therapy program for select blood cancers, fundamentally redefining how advanced cellular therapies can be delivered safely outside of a hospital setting and earning the program a 2026 ACCC Innovator Award.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Centering Compassion in Cancer Care – [Video Podcast] Ep. 64

A Pharmacist-Led Care Model for Oncolytic Virus Treatment Delivery - [Mini Podcast] Ep. 236

The Urology-Oncology Partnership in ADCs - [Video Podcast] Ep. 63

A Team Approach to ADCs in Bladder Cancer – [Video Podcast] Ep. 62

View All Podcasts

Latest from Oncology Issues

June 2026
June 2026
April 2026
February 2026
December 2025
October 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login